Institute of Biomedical Engineering, University of Oxford, Oxford, UK.
NIHR Oxford Biomedical Research Centre, Oxford, UK.
Int J Hyperthermia. 2022 Dec;39(1):918-934. doi: 10.1080/02656736.2022.2091799.
PanDox is a Phase-1 trial of chemotherapeutic drug delivery to pancreatic tumors using ultrasound-mediated hyperthermia to release doxorubicin from thermally sensitive liposomes. This report describes trial-related hyperthermia simulations featuring: (i) new ultrasonic properties of human pancreatic tissues, (ii) abdomen deflections imposed by a water balloon, and (iii) respiration-driven organ motion.
Pancreas heating simulations were carried out using three patient body models. Pancreas acoustic properties were varied between values found in the literature and those determined from our human tissue study. Acoustic beam distortion was assessed with and without balloon-induced abdomen deformation. Target heating was assessed for static, normal respiratory, and jet-ventilation-controlled pancreas motion.
Human pancreatic tumor attenuation is 63% of the literature values, so that pancreas treatments require commensurately higher input intensity to achieve adequate hyperthermia. Abdominal wall deformation decreased the peak field pressure by as much as 3.5 dB and refracted the focal spot by as much as 4.5 mm. These effects were thermally counteracted by sidelobe power deposition, so the net impact on achieving mild hyperthermia was small. Respiratory motion during moving beam hyperthermia produced localized regions overheated by more than 8.0 °C above the 4.0 °C volumetric goal. The use of jet ventilation reduced this excess to 0.7 °C and yielded temperature field uniformity that was nearly identical to having no respiratory motion.
Realistic modeling of the ultrasonic propagation environment is critical to achieving adequate mild hyperthermia without the use of real time thermometry for targeted drug delivery in pancreatic cancer patients.
PanDox 是一项 1 期临床试验,旨在通过超声介导的热疗将化疗药物递送至胰腺肿瘤,利用热敏脂质体从热疗中释放阿霉素。本报告描述了与试验相关的热疗模拟,包括:(i)人胰腺组织的新超声特性,(ii)水球引起的腹部变形,以及(iii)呼吸驱动的器官运动。
使用三个患者体模进行胰腺加热模拟。胰腺的声特性在文献值和我们的人体组织研究值之间进行了变化。评估了有无气球引起的腹部变形时的声束失真。针对静态、正常呼吸和射流通气控制的胰腺运动评估了目标加热。
人胰腺肿瘤的衰减是文献值的 63%,因此胰腺治疗需要相应提高输入强度以实现充分的热疗。腹壁变形使峰值场压降低了多达 3.5 dB,并使焦点折射了多达 4.5 mm。这些影响通过旁瓣功率沉积得到了热补偿,因此对实现轻度热疗的影响很小。在移动波束热疗过程中的呼吸运动导致局部区域过热,超过 4.0°C 容积目标温度 8.0°C 以上。使用射流通气将这种过热降低到 0.7°C,并使温度场均匀度几乎与没有呼吸运动时相同。
在不使用实时测温的情况下,为胰腺癌患者实现靶向药物输送所需的充分轻度热疗,对超声传播环境进行现实建模至关重要。